JPRN-jRCTs032220618招募中Unknown
Exploratory study on clinical applications of photon counting detector CT
Kobayashi Tatsushi0 个研究点目标入组 360 人开始时间: 2023年2月8日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 360
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1. Voluntary written consent to participate in this study has been obtained.
- •2. Aged 20 years or older on the date of informed consent.
- •3. ECOG Performance Status is 0.
- •4. Expected survival of 12 weeks or more.
- •5. Has been diagnosed with or suspected of having a solid tumor.
- •6. No history of hypersensitivity to iodinated contrast media and no contraindications to the use of iodinated contrast media
- •7. Renal function within 30 days before enrollment: eGFR 45 or higher (no CKD or CKD stage 1, 2, or 3a). If multiple renal function tests are available, the result of the renal test which is closest to the date of the protocol test will be used.
- •8. Those who required a contrast-enhanced CT examination at our hospital (National Cancer Center Hospital East)
- •9. Continuing examination and treatment for definitive diagnosis etc. are scheduled at our hospital (National Cancer Center Hospital East).
- •Cohort 2, standard dose group (Criteria 1-8 are common to Cohort 1 and Cohort 2 standard groups, and only criteria 9 is added in Cohort 1. If consent is obtained, simultaneous enrollment is permitted in both Cohort 1 and Cohort 2 standard groups.)
- •1. Voluntary written consent to participate in this study has been obtained.
- •2. Aged 20 years or older on the date of informed consent.
- •3. ECOG Performance Status is 0.
- •4. Expected survival of 12 weeks or more.
- •5. Has been diagnosed with or suspected of having a solid tumor.
- •6. No history of hypersensitivity to iodinated contrast media and no contraindications to the use of iodinated contrast media
- •7. Renal function within 30 days before enrollment: eGFR 45 or higher (no CKD or CKD stage 1, 2, or 3a)
- •8. Those who required a contrast-enhanced CT examination at our hospital (National Cancer Center Hospital East)
- •Cohort 2, reduced dose group
- •1. Voluntary written consent to participate in this study has been obtained.
- •2. Aged 20 years or older on the date of informed consent.
- •3. ECOG Performance Status is 0.
- •4. Expected survival of 12 weeks or more.
- •5. Has been diagnosed with or suspected of having a solid tumor.
- •6. No history of hypersensitivity to iodinated contrast media and no contraindications to the use of iodinated contrast media
- •7. Renal function within 30 days before enrollment: eGFR ranging from 30 or higher to 44 (CKD stage 3b)
- •8. Those who required a contrast-enhanced CT examination at our hospital (National Cancer Center Hospital East)
- •9. Scheduled reevaluation of renal function test basically within the 3 days (maximum 7 days in case of the weekend) after the protocol test.
排除标准
- •Cohort 1 and Cohort 2 (standard dose and reduced dose groups)
- •1. a person with a cardiac pacemaker
- •2. a woman with pregnant or breastfeeding.
- •3. other serious acute or chronic medically significant conditions
- •4. When the principal investigator or co-investigator determines that enrollment in this study is inappropriate.
- •Cohort 2, standard dose and reduced dose groups
- •5. Not scheduled reevaluation of renal function test within the 30 days after the protocol test.
研究者
相似试验
进行中（未招募）
不适用
Etude de l’efficacité thérapeutique de la photothérapie dynamique (PDT) dans le lichen scléreux génital et les dysplasies génitales résistantes aux traitements conventionnels.lichen sclerosusgenital dysplasiaMedDRA version: 12.0Level: LLTClassification code 10024434Term: Lichen sclerosusMedDRA version: 12.0Level: LLTClassification code 10051999Term: Anogenital dysplasiaEUCTR2009-015640-42-BE
尚未招募
4 期
Study to find how homeopathic medicines help with nearsightedness (myopia)CTRI/2024/03/064704Vinayaka Missions Homoeopathic Medical College and Hospital
已完成
不适用
Clinical and Biomarker Study of the Efficacy of Extracorporeal Photopheresis in Graft-versus-host DiseaseGraft-versus-host DiseaseNCT03124056Fundación para la Investigación del Hospital Clínico de Valencia62
招募中
3 期
Evaluation of clinical applications of fluorescent imaging to liver surgery using injection of indocyanine green on the previous day of the operatioiver cancersJPRN-UMIN000013112Department of Surgery, Kanai Medical University100
暂停
2 期
Study of the effects of photodynamic therapy for patients with cervical intraepithlial neoplasia on vaginal bacteriaCervical intraepithelial neoplasiaJPRN-jRCTs041230002Hirotake Murakami20